The visceral sensitivity index: A novel tool for measuring GI-symptom-specific anxiety in inflammatory bowel disease.
anxiety
inflammatory bowel diseases
irritable bowel syndrome
quality of life
severity of illness index
Journal
Neurogastroenterology and motility
ISSN: 1365-2982
Titre abrégé: Neurogastroenterol Motil
Pays: England
ID NLM: 9432572
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
revised:
21
03
2022
received:
02
09
2021
accepted:
22
03
2022
pubmed:
29
4
2022
medline:
31
8
2022
entrez:
28
4
2022
Statut:
ppublish
Résumé
Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are chronic gastrointestinal (GI) disorders. GI symptom-specific anxiety (GSA) is the cognitive, affective, and behavioral response stemming from fear of GI symptoms. The Visceral Sensitivity Index (VSI) measures GSA and is validated in IBS and may be useful in IBD. We compared VSI scores in IBD participants to IBS participants and healthy controls (HCs). Using validated questionnaires, we assessed the VSI's correlation with anxiety, health-related quality of life (HRQOL), and IBD activity. We recruited 222 age- and sex-matched participants (74 IBD [23 Crohn's disease; 51 ulcerative colitis], 74 IBS, and 74 HCs). IBD and IBS participants had higher VSI scores compared with HCs (IBD = 26.62 ± 16.64, IBS = 38.83 ± 15.06; HCs = 3.42±5.06; all p's < 0.001). VSI scores were lower in IBD vs IBS (p < 0.001). In IBD, VSI modestly correlated with current anxiety (R = 0.35, p = 0.002) and the physical component of HRQOL (R = -0.45, p = 0.0001) but less with the mental component of HRQOL (R = -0.23, p = 0.05). Our findings suggest the VSI is a useful measure in IBD. The VSI in IBD is related to general anxiety but is measuring a different construct and is not affected by the presence of trait anxiety. IBD patients have GSA that is associated with decreased HRQOL, which can negatively affect treatment compliance and other long-term disease outcomes. Future studies are needed to further validate the VSI in IBD and to assess its correlation with disease activity.
Sections du résumé
BACKGROUND
Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are chronic gastrointestinal (GI) disorders. GI symptom-specific anxiety (GSA) is the cognitive, affective, and behavioral response stemming from fear of GI symptoms. The Visceral Sensitivity Index (VSI) measures GSA and is validated in IBS and may be useful in IBD.
METHODS
We compared VSI scores in IBD participants to IBS participants and healthy controls (HCs). Using validated questionnaires, we assessed the VSI's correlation with anxiety, health-related quality of life (HRQOL), and IBD activity.
KEY RESULTS
We recruited 222 age- and sex-matched participants (74 IBD [23 Crohn's disease; 51 ulcerative colitis], 74 IBS, and 74 HCs). IBD and IBS participants had higher VSI scores compared with HCs (IBD = 26.62 ± 16.64, IBS = 38.83 ± 15.06; HCs = 3.42±5.06; all p's < 0.001). VSI scores were lower in IBD vs IBS (p < 0.001). In IBD, VSI modestly correlated with current anxiety (R = 0.35, p = 0.002) and the physical component of HRQOL (R = -0.45, p = 0.0001) but less with the mental component of HRQOL (R = -0.23, p = 0.05).
CONCLUSIONS & INFERENCES
Our findings suggest the VSI is a useful measure in IBD. The VSI in IBD is related to general anxiety but is measuring a different construct and is not affected by the presence of trait anxiety. IBD patients have GSA that is associated with decreased HRQOL, which can negatively affect treatment compliance and other long-term disease outcomes. Future studies are needed to further validate the VSI in IBD and to assess its correlation with disease activity.
Identifiants
pubmed: 35478469
doi: 10.1111/nmo.14384
pmc: PMC9427691
mid: NIHMS1798708
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14384Subventions
Organisme : NCCIH NIH HHS
ID : R01 AT007137
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK048351
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK041301
Pays : United States
Organisme : NIDDK NIH HHS
ID : P50 DK064539
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK106528
Pays : United States
Informations de copyright
© 2022 John Wiley & Sons Ltd.
Références
Int J Med Educ. 2011 Jun 27;2:53-55
pubmed: 28029643
Gut. 1998 Jul;43(1):29-32
pubmed: 9771402
Biol Psychiatry. 2009 May 1;65(9):732-41
pubmed: 19150053
Clin Gastroenterol Hepatol. 2016 Jun;14(6):829-835.e1
pubmed: 26820402
Am J Gastroenterol. 1999 Oct;94(10):2929-35
pubmed: 10520847
Gastroenterology. 2006 Apr;130(5):1480-91
pubmed: 16678561
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Gastroenterol Res Pract. 2012;2012:106502
pubmed: 22778720
Gastroenterology. 2016 Feb 18;:
pubmed: 27144627
Psychosomatics. 1993 May-Jun;34(3):229-34
pubmed: 8493304
J Psychosom Res. 2016 Aug;87:70-80
pubmed: 27411754
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
Psychoneuroendocrinology. 2010 Jun;35(5):653-62
pubmed: 19910123
Gastroenterology. 1976 Mar;70(3):439-44
pubmed: 1248701
Inflamm Bowel Dis. 2006 Jan;12(1):47-52
pubmed: 16374258
J Rheumatol Suppl. 2011 Nov;88:48-54
pubmed: 22045979
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S467-72
pubmed: 22588767
Aust N Z J Med. 1995 Aug;25(4):302-8
pubmed: 8540870
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Psychosom Med. 2007 Jan;69(1):89-98
pubmed: 17244851
Neurogastroenterol Motil. 2010 Jun;22(6):646-e179
pubmed: 20367800
Br J Clin Psychol. 1992 Sep;31(3):301-6
pubmed: 1393159
Scand J Gastroenterol. 1978;13(7):833-7
pubmed: 364626
Am J Gastroenterol. 2002 Feb;97(2):389-96
pubmed: 11866278
Gastroenterology. 2000 Sep;119(3):654-60
pubmed: 10982758
Annu Rev Psychol. 2000;51:201-26
pubmed: 10751970
Am J Gastroenterol. 2012 Mar;107(3):451-9
pubmed: 22085819
Eur J Gastroenterol Hepatol. 2010 Jul;22(7):862-7
pubmed: 19701092
Psychol Bull. 1992 Jul;112(1):155-9
pubmed: 19565683
Cytokine. 1998 Apr;10(4):313-8
pubmed: 9617578
Aliment Pharmacol Ther. 2004 Jul 1;20(1):89-97
pubmed: 15225175